These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sensitization and oscillation following repeated stimulation: relationship to affective illness and its treatment with lithium and carbamazepine [proceedings]. Post RM Psychopharmacol Bull; 1980 Oct; 16(4):50-2. PubMed ID: 7454937 [No Abstract] [Full Text] [Related]
3. [The use of carbamazepine in affective disorders]. Beresewicz M Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553 [TBL] [Abstract][Full Text] [Related]
4. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium. Kaschka WP; Thürauf N; Mokrusch T; Korth M Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776 [No Abstract] [Full Text] [Related]
5. Biochemical mechanisms of action of carbamazepine in affective illness and epilepsy. Post RM; Rubinow DR; Uhde TW Psychopharmacol Bull; 1984; 20(3):585-9. PubMed ID: 6473665 [No Abstract] [Full Text] [Related]
6. Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders. Gross R; Grunhaus L South Med J; 1995 Feb; 88(2):249-50. PubMed ID: 7839179 [No Abstract] [Full Text] [Related]
7. [Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan]. Okuma T Seishin Shinkeigaku Zasshi; 2005; 107(5):415-22. PubMed ID: 15981617 [TBL] [Abstract][Full Text] [Related]
8. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine]. Dardennes R; Lafuma A; Watkins S Encephale; 1999; 25(5):391-400. PubMed ID: 10598301 [TBL] [Abstract][Full Text] [Related]
9. Practical therapeutics: the use of carbamazepine in affective disorders. Obel AO; Odwako DB East Afr Med J; 1985 Mar; 62(3):224-8. PubMed ID: 4017925 [No Abstract] [Full Text] [Related]
10. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders. Bowden CL J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401 [No Abstract] [Full Text] [Related]
11. Carbamazepine in recurrent affective disorders? Drug Ther Bull; 1986 Jul; 24(15):59-60. PubMed ID: 3525079 [No Abstract] [Full Text] [Related]
12. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness]. Roick C; Ahrens B; Becker T Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the psychotropic action of lithium and carbamazepine. Rybakowski J Pharmacol Toxicol; 1992; 71 Suppl 1():30-41. PubMed ID: 1480559 [No Abstract] [Full Text] [Related]
14. Carbamazepine for patients with affective target symptoms. Jann MW; Saklad SR; Ereshefsky L Drug Intell Clin Pharm; 1984 Jan; 18(1):81. PubMed ID: 6692752 [No Abstract] [Full Text] [Related]
15. Lithium in the prophylaxis of affective disorders: a twenty years experience. Hanus H; Zapletálek M; Kindernayová H; Tůma I Act Nerv Super (Praha); 1989 Apr; 31(1):27. PubMed ID: 2781994 [No Abstract] [Full Text] [Related]
16. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385 [TBL] [Abstract][Full Text] [Related]
17. Carbamazepine and hyponatremia. Vieweg WV; Godleski LS Am J Psychiatry; 1988 Oct; 145(10):1323-4. PubMed ID: 3421371 [No Abstract] [Full Text] [Related]
18. Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders. Arató M; Rihmer Z; Felszeghy K Biol Psychiatry; 1980 Apr; 15(2):319-22. PubMed ID: 6251928 [No Abstract] [Full Text] [Related]
19. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Berrettini WH; Nurnberger JI; Hare TA; Simmons-Alling S; Gershon ES; Post RM Biol Psychiatry; 1983 Feb; 18(2):185-94. PubMed ID: 6403063 [TBL] [Abstract][Full Text] [Related]